![conference banner](/images/conference-banner.jpeg)
Abstract
Aims: A network pharmacological analysis combined with experimental validation was used to investigate the neuroprotective mechanism of the natural product Tetramethylpyrazine (TMP).
Background: Protecting neurons is critical for acute ischemic stroke treatment. Tetramethylpyrazine is a bioactive component extracted from Chuanxiong. The neuroprotective potential of TMP has been reported, but a systematic analysis of its mechanism has not been performed.
Objective: Based on the hints of network pharmacology and bioinformatics analysis, the mechanism by which TMP alleviates oxygen-glucose deprivation-induced neuronal damage through inhibition of the HIF-1α/BNIP3 pathway was verified.
Methods: In this study, we initially used network pharmacology and bioinformatics analyses to elucidate the mechanisms involved in TMP's predictive targets on a system level. The HIF-1α/BNIP3 pathway mediating the cellular response to hypoxia and apoptosis was considered worthy of focus in the bioinformatic analysis. An oxygen-glucose deprivation (OGD)-induced PC12 cell injury model was established for functional and mechanical validation. Cell viability, lactate dehydrogenase leakage, intracellular reactive oxygen species, percentage of apoptotic cells, and Caspase-3 activity were determined to assess the TMP's protective effects. Transfection with siRNA/HIF-1α or pcDNA/HIF-1α plasmids to silence or overexpress hypoxia-inducible factor 1α (HIF-1α). The role of HIF-1α in OGD-injured cells was observed first. After that, TMP's regulation of the HIF-1α/BNIP3 pathway was investigated. The pcDNA3.1/HIF-1α-positive plasmids were applied in rescue experiments.
Results: The results showed that TMP dose-dependently attenuated OGD-induced cell injury. The expression levels of HIF-1α, BNIP3, and the Bax/Bcl-2 increased significantly with increasing OGD duration. Overexpression of HIF-1α decreased cell viability, increased BNIP3 expression, and Bax/Bcl-2 ratio; siRNA-HIF-1α showed the opposite effect. TMP treatment suppressed HIF-1α, BNIP3 expression, and the Bax/Bcl-2 ratio and was reversed by HIF-1α overexpression.
Conclusion: Our study shows that TMP protects OGD-damaged PC12 cells by inhibiting the HIF-1α/BNIP3 pathway, which provides new insights into the mechanism of TMP and its neuroprotective potential.
Keywords: Tetramethylpyrazine, neuroprotection, oxygen-glucose deprivation, hypoxia-inducible factor 1α, apoptosis, ROS.
[http://dx.doi.org/10.1016/S0140-6736(16)31460-X] [PMID: 27733283]
[http://dx.doi.org/10.1016/j.neuron.2010.07.002] [PMID: 20670828]
[http://dx.doi.org/10.1038/s41582-018-0002-2] [PMID: 29674752]
[http://dx.doi.org/10.1016/j.fct.2018.02.050] [PMID: 29486278]
[http://dx.doi.org/10.1155/2016/2124638] [PMID: 27668034]
[http://dx.doi.org/10.1155/2016/2430329]
[http://dx.doi.org/10.3109/13880209.2011.576346] [PMID: 22014266]
[http://dx.doi.org/10.1016/j.biopha.2022.113005] [PMID: 35483189]
[http://dx.doi.org/10.1016/S0378-5173(01)00572-5] [PMID: 11274807]
[http://dx.doi.org/10.1016/j.apsb.2013.12.009] [PMID: 26579367]
[http://dx.doi.org/10.1016/j.expneurol.2013.04.010] [PMID: 23644042]
[http://dx.doi.org/10.1016/j.bbrc.2015.05.088] [PMID: 26043690]
[http://dx.doi.org/10.1016/j.ejphar.2019.04.028] [PMID: 31004602]
[http://dx.doi.org/10.1371/journal.pone.0105944] [PMID: 25237906]
[http://dx.doi.org/10.1016/j.biopha.2017.07.162] [PMID: 28802236]
[http://dx.doi.org/10.1002/iub.1704] [PMID: 29247598]
[http://dx.doi.org/10.3389/fphar.2020.01063] [PMID: 32848728]
[http://dx.doi.org/10.1007/s10571-012-9803-9] [PMID: 22297543]
[PMID: 30548473]
[http://dx.doi.org/10.1523/JNEUROSCI.4555-04.2005] [PMID: 15843612]
[http://dx.doi.org/10.1177/0271678X15624933] [PMID: 26746864]
[http://dx.doi.org/10.1523/JNEUROSCI.0449-07.2007] [PMID: 17554006]
[http://dx.doi.org/10.2174/1570159X16666180110130253] [PMID: 29318974]
[http://dx.doi.org/10.1093/nar/gkx356] [PMID: 28472511]
[http://dx.doi.org/10.1093/nar/gkz401] [PMID: 31114916]
[http://dx.doi.org/10.1126/science.1059796] [PMID: 11292861]
[http://dx.doi.org/10.1111/apha.12117] [PMID: 23692777]
[http://dx.doi.org/10.1016/j.brainres.2016.10.014] [PMID: 27769790]
[http://dx.doi.org/10.1111/j.1471-4159.2011.07589.x] [PMID: 22097881]
[http://dx.doi.org/10.12659/MSM.904554] [PMID: 29104282]
[http://dx.doi.org/10.1016/j.nbd.2011.10.020] [PMID: 22061780]
[http://dx.doi.org/10.1007/s12264-008-0089-3] [PMID: 18369388]
[http://dx.doi.org/10.1179/1476830515Y.0000000026] [PMID: 25941748]
[http://dx.doi.org/10.1080/13880209.2017.1281968] [PMID: 28140748]
[http://dx.doi.org/10.1111/j.1750-3639.2010.00443.x] [PMID: 21029239]
[http://dx.doi.org/10.1016/j.neuint.2005.12.008] [PMID: 16464515]
[http://dx.doi.org/10.1073/pnas.97.16.9082] [PMID: 10922063]
[http://dx.doi.org/10.1159/000374076] [PMID: 25967972]
[http://dx.doi.org/10.1186/s12986-020-0432-x] [PMID: 32021640]
[http://dx.doi.org/10.7150/thno.22237] [PMID: 29344293]
[http://dx.doi.org/10.1111/j.1745-7254.2007.00514.x] [PMID: 17302993]